Nav: Home

Seeing shapeshifting receptors at work could yield new drugs

January 10, 2019

DURHAM, N.C. -- Blood pressure drugs, like many medications in use today, often have 'off-target' effects because we don't yet understand exactly how they work.

New research out of Duke, UCLA, Stanford and Harvard is showing precisely how the crucial cell surface receptors interact differently with various drugs, giving the researchers hope that they may be able to tailor more specific medications for heart patients.

High blood pressure affects one in three American adults, increasing the risk of heart disease and stroke for about 75 million Americans.

The blood vessel constriction which raises blood pressure is triggered by the interaction of a hormone, angiotensin II, with the angiotensin receptor on the surface of cells in the heart, blood vessels, kidney, adrenal cortex, lungs and brain. Blood pressure drugs called angiotensin receptor blockers (ARBs) treat high blood pressure by preventing angiotensin II from binding to its receptor.

But in doing so, these drugs also block angiotensin II's beneficial effects, including increases in the heart's strength and performance.

Ideally, physicians would like to block the angiotensin receptor's effects on blood pressure without losing its positive effects on heart function, said cardiologist Robert Lefkowitz, M.D., the James B. Duke professor of Medicine and senior author of one of two companion papers coming out in Cell on Jan. 10.

Duke researchers collaborated with scientists across the country to determine the various shapes the angiotensin receptor assumes when it is turned on by different types of drugs, a key step towards being able to design better heart medicines.

"For a long time, people assumed that these receptors had one 'off state' and one 'on state,' like a light switch," said lead author Laura Wingler, Ph.D., a postdoctoral researcher in the Lefkowitz laboratory. "But they aren't light switches; these receptors are more like dials with multiple settings, or states. What's been unclear for the past 10 years is what these receptor states look like and why each state triggers different events inside the cell."

Just as squeezing only the top of a balloon alters its entire shape, the binding of hormones and drugs to the outside of a receptor causes changes in parts of the receptor which face into the cell. Different hormones and drugs push different "buttons" on a receptor, changing its shape in different ways.

Seeing those specific shapes of the angiotensin receptor for the first time "helps us approach the design of drugs more rationally," Wingler said. "Now we know what to be aiming for and the mechanisms we need to target."

The Duke-led study, which included colleagues at UCLA and Stanford, used a sophisticated technique called double electron-electron resonance spectroscopy to map the shape of the receptor when it interacts with different classes of hormones and drugs.

"It's like seeing a silhouette of the receptor -- an outline of its shape from one viewpoint," Wingler said.

The researchers discovered that the receptor assumes four main shapes: one associated with ARBs that turn the receptor completely off, one associated with angiotensin II and drugs that turn the receptor fully on (both increasing blood pressure and improving heart function), and two associated with the drugs that improve heart function without increasing blood pressure.

In a second paper, the Duke group worked with the laboratory of Andrew C. Kruse, a professor at Harvard Medical School, to use X-ray crystallography to see the fine details of the receptor when it is frozen in the "fully on" state.

Wingler compares this approach to seeing an intricate, three-dimensional statue of the receptor. Importantly, it let them see how one drug interacts with the receptor and what "buttons" it presses to change the shape of the receptor.

The angiotensin receptor is a member of a family of proteins called G protein-coupled receptors (GPCRs), which sit in the membrane that surrounds cells and interact with hormones and drugs in the bloodstream. The GPCR family includes receptors for adrenaline, histamine, opioids, and the many molecules responsible for taste and smell, and they are the target of about one-third of all FDA-approved drugs.

Lefkowitz and Stanford University Professor Brian Kobilka, a senior co-author on one of the Cell papers, shared the 2012 Nobel Prize in Chemistry for discovering the GPCR family and defining how these receptors work.

The researchers hope these latest findings may lead to tailor-made drugs for other GPCRs that could separate desired therapeutic effects from unwanted side effects.

For example, these same principles have already been used to develop new drugs for the opioid receptor that have advanced to clinical trials. These next-generation opioid receptor drugs relieve pain but are less prone to cause the side effects associated with morphine and fentanyl, such as constipation and potentially lethal slowed breathing.

"Our papers go way beyond anything which has been done in this field before," Lefkowitz said. "This research is likely to lead to discovery and development of novel types of drugs which can manipulate these receptors' shapes in ways that have not previously been possible."
-end-
The research was partially funded by National Institutes of Health grants (RO1HL016037), the Mandel Center for Hypertension and Atherosclerosis at Duke and the Howard Hughes Medical Institute.

CITATIONS: "Angiotensin analogs with divergent bias stabilize distinct receptor conformations," Laura M. Wingler, Matthias Elgeti, Daniel Hilger, Naomi R. Latorraca, Michael T. Lerch, Dean P. Staus, Ron O. Dror, Brian K. Kobilka, Wayne L. Hubbell, Robert J. Lefkowitz, Cell, Jan. 10, 2019. DOI: 10.1016/j.cell.2018.12.005

"Distinctive Activation Mechanism for Angiotensin Receptor Revealed by a Synthetic Nanobody," Laura M. Wingler, Conor McMahon, Dean P. Staus, Robert J. Lefkowitz, Andrew C. Kruse. Cell, Jan. 10, 2019. DOI: 10.1016/j.cell.2018.12.006

Duke University

Related Blood Pressure Articles:

Do you really have high blood pressure?
A study by researchers at the University of Montreal Hospital Research Centre (CRCHUM) shows that more than half of family doctors in Canada are still using manual devices to measure blood pressure, a dated technology that often leads to misdiagnosis.
Why do we develop high blood pressure?
Abnormally high blood pressure, or hypertension, may be related to changes in brain activity and blood flow early in life.
For some, high blood pressure associated with better survival
Patients with both type 2 diabetes and acute heart failure face a significantly lower risk of death but a higher risk of heart failure-related hospitalizations if they had high systolic blood pressure on discharge from the hospital compared to those with normal blood pressure, according to a study scheduled for presentation at the American College of Cardiology's 66th Annual Scientific Session.
$9.4 million grant helps scientists explore how cell death from high blood pressure fuels even higher pressure
It's been known for decades that a bacterial infection can raise your blood pressure short term, but now scientists are putting together the pieces of how our own dying cells can fuel chronically high, destructive pressure.
Blood pressure diet improves gout blood marker
A diet rich in fruits, vegetables, low-fat dairy and reduced in fats and saturated fats (the DASH diet), designed decades ago to reduce high blood pressure, also appears to significantly lower uric acid, the causative agent of gout.
New tool to improve blood pressure measurement
Oxford University researchers have developed a prediction model that uses three separate blood pressure readings taken in a single consultation and basic patient characteristics to give an adjusted blood pressure reading that is significantly more accurate than existing models for identifying hypertension.
Blood vessels sprout under pressure
It is blood pressure that drives the opening of small capillaries during angiogenesis.
Better blood pressure control -- by mobile phone
An interactive web system with the help of your mobile phone can be an effective tool for better blood pressure control.
Time to reassess blood-pressure goals
High blood pressure or hypertension is a major health problem that affects more than 70 million people in the US, and over one billion worldwide.
With help from pharmacists, better blood pressure costs $22
A pharmacist-physician collaboration in primary-care offices effectively and inexpensively improved patients' high blood pressure.

Related Blood Pressure Reading:

The High Blood Pressure Hoax
by Sherry A. Rogers (Author)

Thirty Days to Natural Blood Pressure Control: The No Pressure Solution
by MPH, David DeRose MD (Author), MPH, Greg Steinke MD (Author), Trudie Li FNP (Author), Clifford Goldstein (Editor)

Blood Pressure Down: The 10-Step Plan to Lower Your Blood Pressure in 4 Weeks--Without Prescription Drugs
by Janet Bond Brill PhD RD (Author)

Reversing Hypertension: A Vital New Program to Prevent, Treat, and Reduce High Blood Pressure
by Julian Whitaker (Author)

Lower Your Blood Pressure: A 21-Day DASH Diet Meal Plan to Decrease Blood Pressure Naturally
by Jennifer Koslo PhD RDN CSSD (Author)

Blood Pressure: Blood Pressure Solution : The Ultimate Guide to Naturally Lowering High Blood Pressure and Reducing Hypertension (Blood Pressure Series) (Volume 1)
by Mark Evans (Author)

Blood Pressure Solution: The Path to Naturally Lower and Control your Blood Pressure, Without Medication
by Margaret Schmitt (Author)

Harvard Medical School Guide to Lowering Your Blood Pressure (Harvard Medical School Guides)
by Aggie Casey (Author), Herbert Benson (Author)

High Blood Pressure
by RosettaBooks

Blood Pressure Solution: 30 Proven Natural Superfoods To Control & Lower Your High Blood Pressure (Natural Remedies, Naturally Reduce Hypertension, Superfoods)

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Approaching With Kindness
We often forget to say the words "thank you." But can those two words change how you — and those around you — look at the world? This hour, TED speakers on the power of gratitude and appreciation. Guests include author AJ Jacobs, author and former baseball player Mike Robbins, Dr. Laura Trice, Professor of Management Christine Porath, and former Danish politician Özlem Cekic.
Now Playing: Science for the People

#509 Anisogamy: The Beginning of Male and Female
This week we discuss how the sperm and egg came to be, and how a difference of reproductive interest has led to sexual conflict in bed bugs. We'll be speaking with Dr. Geoff Parker, an evolutionary biologist credited with developing a theory to explain the evolution of two sexes, about anisogamy, sexual reproduction through the fusion of two different gametes: the egg and the sperm. Then we'll speak with Dr. Roberto Pereira, research scientist in urban entomology at the University of Florida, about traumatic insemination in bed bugs.